Scholars Central

Mini reviewPublished 20 Jun 2017

NLRP3 Inflammasome: From Pathogenesis to Therapeutic Strategies in Type 1 Diabetes

Authors: Daniela Carlos

Journal of Autoimmune Disorders

Volume 3 · Issue 2 · Pages 6

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Type 1 diabetes mellitus (T1DM) is an autoimmune disease characterized by a T-cell-mediated destruction of the pancreatic β cells. Several environmental factors have been proposed as candidate triggers for T1DM, considering that a genetic predisposition alone is not sufficient to explain the increasing incidence rates over the past decades. This organ-specific autoimmune disease is the consequence of multifactorial processes involving dysregulation of the innate and adaptive immune systems that lead the body to damage insulin-producing β cells. In this review, we reported the contribution of innate immune receptors in modulating the pathogenic lymphocyte responses in T1DM development, with a particular emphasis to NLRP3, which can be considered as a potential therapeutic target to treat T1DM.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Autoimmune Disorders.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Autoimmune Disorders
  • SubjectImmunology & Microbiology
  • BylineArticles whose byline prints “Daniela Carlos”